Sentence examples for weeks were implanted from inspiring English sources

Female BALB/c athymic mice (6 8 weeks) were implanted with a variety of tumours.

Osmotic minipumps (Alza Corp ,USA) containing AngII (0.4 or 0.8 mg/kg/day for 4 weeks) were implanted subcutaneously.

Osmotic pumps (2ML4; Durect, Cupertino, CA), which were designed to allow the continuous infusion of test drugs over a period of 4 weeks, were implanted subcutaneously along the spine.

BMSs (n = 21, 7 for one week, 5 for two weeks, and 9 for four weeks), PCSs (n = 16, 5 for one week, 5 for two weeks, and 6 for four weeks), and AESs (n = 32, 9 for one week, 11 for two weeks, and 12 for four weeks) were implanted in 2-3 coronarteriesries per pig by random assignment to anatomic location.

BMS (n = 14, 5 for one week, 4 for two weeks, and 5 for four weeks) and CD133 stents (n = 16, 6 for one week, 5 for two weeks, and 5 for four weeks) were implanted in 2-3 coronarteriesries per pig by random assignment to anatomic location.

The constructs after being in vitro induced for 2 weeks were implanted to repair full thickness articular cartilage defects (8 mm in diameter, deep to subchondral bone) in femur trochlea (the experimental group), while scaffold alone was implanted to serve as the control.

Another group of C57BL/6 mice fed with CDDO-MA-containing or control diet for one week were implanted subcutaneously with osmotic minipumps (Model 2004, Alzet, Cupertino CA, filled with MPTP 170 mg/ml in PBS) that delivered MPTP at a dose of 40 mg/kg body weight daily for 28 day.

A total of 16 female, 3 male Long-Evans rats (350 450 g, 10 16 weeks old) and 8 male Wistar rats (250 450 g, 8 12 weeks old) were implanted with custom-made recording and stimulating electrodes under urethane anesthesia (1.3 1.5 g/kg, intraperitoneal injection) for the extracellular and the whole-cell patch clamp recording experiments, respectively.

The osmotic pumps (Alzet #2004) delivered an NOAEL dose of 23.4 and 26.7 μg/h of DT310 and DT320, respectively, for 4 weeks and were implanted as directed subcutaneously posterior to scapulae.

To assess the effect of intracerebroventricular peptide injection on feeding behavior, adult (8 9 weeks) male mice were implanted with a cannula over the right lateral ventricle, and were allowed to recover for 1 week prior to further manipulation.

Male C57BL/6J mice (16 24 weeks of age) were implanted with chronic intrarenal medullary interstitial (IRMI) and infused with: saline, tempol (6 mM), the HO-1 inhibitor QC-13 (25 μM), or a combination of tempol + QC-13.